» Articles » PMID: 17223013

Expression of Transcripts for Myelination-related Genes in the Anterior Cingulate Cortex in Schizophrenia

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2007 Jan 16
PMID 17223013
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Several recent studies have found changes in the expression of genes functionally related to myelination and oligodendrocyte homeostasis in schizophrenia. These studies utilized microarrays and quantitative PCR (QPCR), methodologies which do not permit direct, unamplified examination of mRNA expression. In addition, these studies generally only examined transcript expression in homogenates of gray matter. In the present study, we examined the expression of myelination-related genes previously implicated in schizophrenia by microarray or QPCR. Using in situ hybridization, we measured transcript expression of 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP), myelin-associated glycoprotein (MAG), transferrin (TF), quaking (QKI), gelsolin, myelin oligodendrocyte glycoprotein, v-erb-b2 erythroblastic leukemia viral oncogene homolog 3, erbb2 interacting protein, motility-related protein-1, SRY-box containing gene 10, oligodendrocyte transcription factor 2, peripheral myelin protein 22, and claudin-11 in both gray and white matter of the anterior cingulate cortex (ACC) in subjects with schizophrenia (n=41) and a comparison group (n=34). We found decreased expression of MAG, QKI, TF, and CNP transcripts in white matter. We did not find any differences in expression of these transcripts between medicated (n=31) and unmedicated (n=10) schizophrenics, suggesting that these changes are not secondary to treatment with antipsychotics. Finally, we found significant positive correlations between QKI and MAG or CNP mRNA expression, suggesting that the transcription factor QKI regulates MAG and CNP expression. Our results support the hypothesis that myelination and oligodendrocyte function are impaired in schizophrenia.

Citing Articles

The multifaceted role of quaking protein in neuropsychiatric disorders and tumor progression.

Guo Z, Liu B, Wei Y, Wang H, Zhang Q, Hong X Front Neurosci. 2024; 18:1341114.

PMID: 39479357 PMC: 11521838. DOI: 10.3389/fnins.2024.1341114.


The Genomic Intersection of Oligodendrocyte Dynamics in Schizophrenia and Aging Unravels Novel Pathological Mechanisms and Therapeutic Potentials.

Rivera A, Normanton J, Butt A, Azim K Int J Mol Sci. 2024; 25(8).

PMID: 38674040 PMC: 11050044. DOI: 10.3390/ijms25084452.


The Effects of Antipsychotics in Experimental Models of Krabbe Disease.

Sharma K, Dev K Biomedicines. 2023; 11(5).

PMID: 37238985 PMC: 10215783. DOI: 10.3390/biomedicines11051313.


Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia.

Matlik K, Garton D, Montano-Rodriguez A, Olfat S, Eren F, Casserly L Mol Psychiatry. 2022; 27(8):3247-3261.

PMID: 35618883 PMC: 9708553. DOI: 10.1038/s41380-022-01554-2.


Insights into myelin dysfunction in schizophrenia and bipolar disorder.

Valdes-Tovar M, Rodriguez-Ramirez A, Rodriguez-Cardenas L, Sotelo-Ramirez C, Camarena B, Sanabrais-Jimenez M World J Psychiatry. 2022; 12(2):264-285.

PMID: 35317338 PMC: 8900585. DOI: 10.5498/wjp.v12.i2.264.


References
1.
Flynn S, Lang D, MacKay A, Goghari V, Vavasour I, Whittall K . Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry. 2003; 8(9):811-20. DOI: 10.1038/sj.mp.4001337. View

2.
Barbarese E, Barry C, DOcchio C, Edgar S, Akowitz A, Carson J . Expression of myelin basic protein mRNA and polypeptides in mouse oligodendrocytes in culture: differential regulation by genetic and epigenetic factors. Brain Res. 1988; 467(2):183-91. DOI: 10.1016/0165-3806(88)90022-3. View

3.
Tkachev D, Mimmack M, Ryan M, Wayland M, Freeman T, Jones P . Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003; 362(9386):798-805. DOI: 10.1016/S0140-6736(03)14289-4. View

4.
Davidson M, Harvey P, Powchik P, Parrella M, White L, Knobler H . Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry. 1995; 152(2):197-207. DOI: 10.1176/ajp.152.2.197. View

5.
Purohit D, Perl D, Haroutunian V, Powchik P, Davidson M, Davis K . Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch Gen Psychiatry. 1998; 55(3):205-11. DOI: 10.1001/archpsyc.55.3.205. View